home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login » Fund III Investor Login »

news

May1CRG Expands Investment Team and Appoints Todd Holmes as Principal »


Boulder, Colorado – May 1st, 2018 – CRG, a leading healthcare investment firm, today announced the appointment of Todd Holmes as Principal in the firm’s Boulder office. Mr. Holmes...

Read More »

Apr26Humana-Walmart Deal Would Be Brilliant On Many Levels: CRG’s Li »


April 26, 2018 - Bloomberg Markets AM with Pimm Fox and Lisa Abramowicz.   GUEST: Scott Li, principal at CRG, a healthcare private investment firm, to discuss investment opportunities in the healthcare...

Read More »

Apr24Valeritas Announces Pricing of $24 Million Public Offering of Common Stock »


Bridewater, N.J., April 24, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable...

Read More »

Apr18CRG Completes Planned Leadership Transition to Nathan Hukill »


-- Founder Charles Tate to serve as Chairman Emeritus --   Boulder, Colo. – April 18th, 2018 – CRG, a leading healthcare investment firm, today announced the completion of the...

Read More »

Apr4bioMérieux Reinforces its Offering of High Medical Value Immunoassay Biomarkers With the Acquisition of Astute Medical »


-- bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis...

Read More »

Mar1Corium Prices Offering of $100 Million of 5% Convertible Senior Notes »


Menlo Park, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the...

Read More »

Feb26ViewRay Announces $59 Million Equity Financing »


-- Financing to Further Support Growth of MRIdian Linac --   Cleveland, Feb. 26, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided...

Read More »

Feb20Dynavax Secures $175 Million in Non-Dilutive Debt Financing »


-- Proceeds to be Used to Commercialize HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] in United States and Advance Company's Immuno-Oncology Product Candidates --   -- Company Deploying HEPLISAV-B...

Read More »

Feb12Viveve Announces Closing of Public Offering of Shares of Common Stock »


Englewood, CO -- (Marketwired) -- 02/12/18 -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced the closing of its previously...

Read More »

Feb9Tandem Diabetes Care Announces Pricing of $60 Million Underwritten Public Offering of Common Stock »


San Diego --(BUSINESS WIRE) --Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today...

Read More »

Jan25Synergy Pharmaceuticals Announces FDA Approval of TRULANCE® (Plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBSC) in Adults »


NEW YORK- (BUSINESS WIRE)-- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today that the U.S. Food and Drug Administration (FDA) has approved TRULANCE ®(plecanatide) 3 mg tablet for the...

Read More »

Jan25Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares »


Dublin, Ireland and Trevose, Pa., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it has priced its...

Read More »

Jan17Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris »


-- MACRILEN is the First and Only FDA-Approved Oral Drug Indicated For the Diagnosis of Adult Growth Hormone Deficiency, a Rare Endocrine Disorder -- -- MACRILEN is Strongbridge...

Read More »

Dec19Synergy Pharmaceuticals Appoints Troy Hamilton Chief Executive Officer »


-- Co-Founder Gary S. Jacob, Ph.D., Named Executive Chairman  --   New York - (BUSINESS WIRE) -- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on...

Read More »

Dec6TearLab Prices $3.0 Million Registered Direct Offering »


San Diego, Dec. 06, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX:TLB) (“TearLab” or the “Company”), today announced the pricing of a registered direct offering of 6,818,182...

Read More »
Load More